WPI Financial Facts
Loss attributable to noncontrolling interest: 700KTotal operating expenses: 1.94B
See Full Income Statement
Marketable securities: 9M
Total liabilities and equity: 14.17B
See Full Balance Sheet
Earnings History for Watson Pharmaceuticals Inc. (WPI)
|
Expand Research on WPI
| Next EPS Date | 2/13/13 *Est. | EPS Growth Rate | +23.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.5% | Revenue Growth Rate | +19.4% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/1/12 |
Q312 | $1.35 | $1.29 | +$0.06 | $1.29B | $1.27B | N/A / N/A | = | -0.3% | Details | |
| 7/26/12 |
Q212 | $1.42 | $1.39 | +$0.03 | $1.36B | $1.35B | N/A / N/A | = | +11.6% | Details | |
| 4/30/12 |
Q112 | $1.64 | $1.60 | +$0.04 | $1.52M | $1.48M | N/A / N/A | = | +12.6% | Details | |
| 2/14/12 |
Q411 | $1.77 | $1.76 | +$0.01 | $1.55B | $1.54B | N/A / N/A | = | +48.6% | Details | |
| 11/1/11 |
Q311 | $1.09 | $1.05 | +$0.04 | $1.08B | $1.09B | N/A / N/A | = | +27.7% | Details | |
| 7/26/11 |
Q211 | $1.01 | $1.00 | +$0.01 | $1.08B | $992.06M | N/A / N/A | = | +23.6% | Details | |
| 4/27/11 |
Q111 | $0.89 | $0.86 | +$0.03 | $877M | $912.33M | N/A / N/A | = | +43.9% | Details | |
| 2/15/11 |
Q410 | $0.93 | $0.93 | $0.00 | $952.7M | $927.64M | N/A / N/A | = | +51.2% | Details |
